MedPath

Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients

Phase 2
Terminated
Conditions
End Stage Renal Failure, Hemodialysis
Registration Number
NCT00563342
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The primary objective of the study is to examine the risk of catheter dysfunction during the dialysis session that follows the instillation of ethanol 60% as lock solution in tunneled silicone catheters of end stage renal failure patients treated by hemodialysis.

The catheters dysfunction rate is the primary outcome. The dysfunction is defined as partial or complete occlusion or infection associated with dialysis catheter.

As a secondary outcome, the dialysis quality is also examined (urea reduction rate, total ultrafiltration)

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients of both genders, over 18 years,
  • Chronic hemodialysis 3 times a week, with two tunnel silicone catheters since at least 15 days,
  • Written informed consent
  • Social security
Exclusion Criteria
  • Antibiotic therapy during selection phase,
  • Partial or complete catheter occlusion during selection phase,
  • Venous pressure at dialysis connection > 300 mmHg,
  • Known allergy to ethanol,
  • Patient involved in any other clinical trial or in the exclusion period
  • Severe co-morbidity
  • Acute or chronic infectious disease
  • Evolutive neoplasia,
  • HIV, HCV positive serology at inclusion,
  • Scheduled surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The catheters dysfunction rateas partial or complete occlusion or infection associated with dialysis catheter
Secondary Outcome Measures
NameTimeMethod
The dialysis quality is also examined (urea reduction rate, total ultrafiltration)as partial or complete occlusion or infection associated with dialysis catheter

Trial Locations

Locations (1)

Lacarin

šŸ‡«šŸ‡·

Clermont-Ferrand, France

Ā© Copyright 2025. All Rights Reserved by MedPath